This round brings the company’s total funding to more than $90 million after it raised $9 million last September as well. Investors included RA Capital Management, Engine Ventures, GHIC and Mission Bio Capital.
Cambridge, Massachusetts-based Vaxess brought in Sha as its CEO after co-founder Michael Schrader elected to step down from the corner office. Sha brings more than 20 years in life sciences, including time spent at Novartis and Genzyme. Most recently, she spent a decade at Sanofi, holding a number of leadership roles across the organization.
Get the full story at our sister site, Drug Delivery Business News.
